Rodrigo Maegawa

Rodrigo Maegawa is an accomplished professional with a diverse background in business and medicine.

He holds a Master of Business Administration (MBA) from NYU Stern School of Business, showcasing his strategic management skills and business acumen.

In addition to his MBA, Rodrigo Maegawa also obtained a Doctor of Medicine (M.D.) degree from Universidade Federal do Paraná, demonstrating his expertise in the medical field.

With a solid educational foundation in both healthcare and business, Rodrigo Maegawa has successfully navigated various roles in prestigious organizations.

Currently, he serves as the US Medical Director at Novartis, where he leads the team at CML Assets, highlighting his leadership capabilities and pharmaceutical industry knowledge.

His previous experiences include holding the position of Medical Director at Lafayette Family Cancer Institute at Eastern Maine Medical Center, showcasing his expertise in oncology and patient care.

Rodrigo Maegawa has also worked as a Stem Cell Transplantation Instructor/Fellow at City of Hope, demonstrating his commitment to advancing medical procedures and treatments.

His background includes a role as a Hematology/Oncology Fellow at the University of Colorado Denver, further solidifying his specialization in oncology and hematology.

Prior to these roles, Rodrigo Maegawa served as an Internal Medicine Intern/Resident at St. Luke's-Roosevelt Hospital, gaining valuable experience in internal medicine and patient care.